Graham Capital Management, L.P. Replimune Group, Inc. Transaction History
Graham Capital Management, L.P.
- $3.11 Billion
- Q2 2024
A detailed history of Graham Capital Management, L.P. transactions in Replimune Group, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 22,625 shares of REPL stock, worth $250,685. This represents 0.01% of its overall portfolio holdings.
Number of Shares
22,625
Previous 91,137
75.17%
Holding current value
$250,685
Previous $744,000
72.72%
% of portfolio
0.01%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding REPL
# of Institutions
153Shares Held
70MCall Options Held
26.7KPut Options Held
28.6K-
Baker Bros. Advisors LP New York, NY10MShares$111 Million1.2% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD9.24MShares$102 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA5.56MShares$61.6 Million3.26% of portfolio
-
Fcpm Iii Services B.V. Naarden, P74.87MShares$53.9 Million6.46% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$52.2 Million0.0% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $546M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...